DOI 10.1016/j.brainres.2026.150474
A promising therapeutic strategy reduces abnormal Aβ deposition and inhibits neuronal apoptosis via FGF17 ameliorating AD-like neurodegeneration.
Аннотация
AIMS: We explore a possible association between dysregulated FGF17 expression and the pathogenesis underlying AD, and discovery efficacious therapeutic strategies.
METHODS
We measured FGF17 levels in serum from AD patients, and selected APP/PS1 mice as well as SH-SY5Y cells stimulated with Aβ1-42 for 24 h as the AD model. Through AAV9-mediated gene delivery (stereotactic injection) or exogenous human recombinant protein administering, we investigated the effects of FGF17 on cell apoptosis phenotype, synaptic defects, and behavioral manifestations.
RESULTS
Our investigation demonstrated diminished FGF17 concentrations in the serum of individuals with AD. Comparable reductions in FGF17 levels appeared in SH-SY5Y cells treated with Aβ1-42 over a 24-hour period, as well as in APP/PS1 mouse brains. Subsequent experiments demonstrated that AAV9-mediated FGF17 gene delivery could alleviate the cognitive impairment of APP/PS1 mice. Moreover, abnormal Aβ deposition and neuronal apoptosis were reduced through FGF17 treatment; the strategy inhibited neuronal damage and synaptic defects. Concurrently, we confirmed that in the aforementioned biological process, the FGFR3/PI3K/AKT signaling pathway was activated. Inhibiting FGFR3 reduced the protective effect of FGF17.
CONCLUSIONS
This study highlights the promising disease-modifying therapies for FGF17 in managing AD. Our research indicates that the approach plays a positive role in both cognitive function and histopathology.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.